Fundraising FoxCytospire Therapeutics
8 known investors
Find your way into Cytospire Therapeutics
Sign up to see every warm intro you have to Cytospire Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cytospire Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers. The company is building a portfolio of immune cell engagers aimed at cancer therapies.
Investors · 8
How we know: Medical Incubator Japan K.K.'s portfolio page · Not right? Tell us
How we know: Modi Ventures's portfolio page · Not right? Tell us
How we know: Pathway Bioventures's portfolio page · Not right? Tell us
How we know: Sound Bioventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Cytospire Therapeutics do?
- Cytospire Therapeutics develops multispecific antibodies and next-generation γδ T cell engagers designed to direct innate and adaptive immune effector cells as an alternative to CD3-based engagers. The company is building a portfolio of immune cell engagers aimed at cancer therapies.
- Who are Cytospire Therapeutics's investors?
- Cytospire Therapeutics's investors include Criteria Bio Ventures, LifeArc Ventures, Medical Incubator Japan K.K., Modi Ventures, Pathway Bioventures, Sound Bioventures, 4BIO Capital, Abingworth.